DAL vs RAPP · P/E 12, rev $61.64B vs $532.9M cap
Delta Air Lines Inc (DAL) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
RAPP does not have a complete income-statement cache yet.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the DAL and RAPP stock pages for the full models.
Not investment advice.